Resmed Operating Margin vs. Price To Sales

RMEA Stock  EUR 21.60  0.20  0.92%   
Based on the measurements of profitability obtained from Resmed's financial statements, Resmed Inc DRC may not be well positioned to generate adequate gross income at the moment. It has a very high risk of underperforming in January. Profitability indicators assess Resmed's ability to earn profits and add value for shareholders.
For Resmed profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Resmed to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Resmed Inc DRC utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Resmed's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Resmed Inc DRC over time as well as its relative position and ranking within its peers.
  
Check out Your Equity Center.
Please note, there is a significant difference between Resmed's value and its price as these two are different measures arrived at by different means. Investors typically determine if Resmed is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Resmed's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Resmed Inc DRC Price To Sales vs. Operating Margin Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Resmed's current stock value. Our valuation model uses many indicators to compare Resmed value to that of its competitors to determine the firm's financial worth.
Resmed Inc DRC is currently regarded as top stock in operating margin category among its peers. It also is currently regarded as top stock in price to sales category among its peers fabricating about  28.55  of Price To Sales per Operating Margin. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Resmed's earnings, one of the primary drivers of an investment's value.

Resmed Price To Sales vs. Operating Margin

Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.

Resmed

Operating Margin

 = 

Operating Income

Revenue

X

100

 = 
0.28 %
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.

Resmed

P/S

 = 

MV Per Share

Revenue Per Share

 = 
8.00 X
The most critical factor to remember is that the price of equity takes a firm's debt into account, whereas the sales indicators do not consider financial leverage. Generally speaking, Price to Sales ratio shows how much market values every dollar of the company's sales.

Resmed Price To Sales Comparison

Resmed is currently under evaluation in price to sales category among its peers.

Resmed Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in Resmed, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Resmed will eventually generate negative long term returns. The profitability progress is the general direction of Resmed's change in net profit over the period of time. It can combine multiple indicators of Resmed, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications that diagnose, treat, and manage respiratory disorders comprising sleep disordered breathing, chronic obstructive pulmonary disease, neuromuscular disease, and other chronic diseases. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California. RESMED CUFS10 is traded on Frankfurt Stock Exchange in Germany.

Resmed Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Resmed. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Resmed position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Resmed's important profitability drivers and their relationship over time.

Use Resmed in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Resmed position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Resmed will appreciate offsetting losses from the drop in the long position's value.

Resmed Pair Trading

Resmed Inc DRC Pair Trading Analysis

The ability to find closely correlated positions to Resmed could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Resmed when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Resmed - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Resmed Inc DRC to buy it.
The correlation of Resmed is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Resmed moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Resmed Inc DRC moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Resmed can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your Resmed position

In addition to having Resmed in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Advertising Thematic Idea Now

Advertising
Advertising Theme
Companies specializing in advertising, marketing and advertising services. The Advertising theme has 42 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Advertising Theme or any other thematic opportunities.
View All  Next Launch

Other Information on Investing in Resmed Stock

To fully project Resmed's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Resmed Inc DRC at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Resmed's income statement, its balance sheet, and the statement of cash flows.
Potential Resmed investors and stakeholders can use historical trends found within financial statements to determine how well the company is positioned for the future. Although Resmed investors may work on each financial statement separately, they are all related. The changes in Resmed's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Resmed's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.